Post-Marketing Surveillance Study of Nalmefene Hydrochloride Hydrate in Patients With Alcohol Dependence
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Know the risks and potential benefits of clinical studies and talk to your health care provider before participating.
Read our disclaimer for details.
The purpose of this study is to investigate the safety and the prognosis after achieving reduced alcohol intake in patients with alcohol dependence who received treatment for the reduction of alcohol intake in the routine clinical setting in Japan.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
Child, Adult, Older Adult
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients with alcohol dependence who are planned to be newly started on nalmefene hydrochloride hydrate for the treatment of reduction of alcohol consumption.
Clinical diagnosis of Alcohol Dependence
Must agree to follow-up during the first year of prescription and publication of survey results
Patients whose goal of treatment for Alcohol Dependence is to reduce alcohol consumption
Patients receiving psychosocial treatment aiming to promote treatment adherence and reduction of alcohol consumption
Patients who have chronic heavy drinking
Patients who have confirmed that they are willing to receive treatment to reduce their alcohol consumption
Patients who has ever been treated with nalmefene hydrochloride hydrate